Holen Sie sich die Stockscreener-App
160.14
2.34%
3.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ORCL?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$156.48
Offen:
$159.25
24-Stunden-Volumen:
18.54M
Relative Volume:
0.66
Marktkapitalisierung:
$460.26B
Einnahmen:
$61.02B
Nettoeinkommen (Verlust:
$15.61B
KGV:
30.10
EPS:
5.3211
Netto-Cashflow:
$-13.18B
1W Leistung:
+12.13%
1M Leistung:
-20.84%
6M Leistung:
-34.42%
1J Leistung:
-7.89%
1-Tages-Spanne:
$155.29
$162.30
1-Wochen-Bereich:
$147.00
$165.39
52-Wochen-Spanne:
$118.86
$345.72
Oracle Corp Stock (ORCL) Company Profile
Firmenname
Oracle Corp
Sektor
Branche
Telefon
(737) 867-1000
Adresse
2300 ORACLE WAY, AUSTIN, CA
Compare ORCL vs MSFT, PLTR, CRWD, SNPS
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ORCL
Oracle Corp
|
160.14 | 449.74B | 61.02B | 15.61B | -13.18B | 5.3211 |
|
MSFT
Microsoft Corporation
|
401.32 | 2.98T | 305.45B | 119.26B | 77.41B | 15.98 |
|
PLTR
Palantir Technologies Inc
|
131.41 | 307.77B | 4.48B | 1.63B | 2.10B | 0.6363 |
|
CRWD
Crowdstrike Holdings Inc
|
429.64 | 103.75B | 4.57B | -315.36M | 1.10B | -1.2634 |
|
SNPS
Synopsys Inc
|
437.09 | 80.99B | 7.05B | 1.34B | 1.35B | 8.0234 |
Oracle Corp Stock (ORCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-09 | Hochstufung | DA Davidson | Neutral → Buy |
| 2026-02-09 | Herabstufung | Melius | Buy → Hold |
| 2026-02-04 | Bestätigt | BMO Capital Markets | Outperform |
| 2026-01-12 | Fortgesetzt | Goldman | Buy |
| 2025-12-11 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-12-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-11-10 | Herabstufung | Erste Group | Buy → Hold |
| 2025-10-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-10-09 | Eingeleitet | Robert W. Baird | Outperform |
| 2025-09-25 | Eingeleitet | Rothschild & Co Redburn | Sell |
| 2025-09-10 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-09-10 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-09-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-09-09 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-07-17 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-07-10 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2025-07-02 | Bestätigt | BMO Capital Markets | Outperform |
| 2025-06-30 | Hochstufung | Stifel | Hold → Buy |
| 2025-06-18 | Bestätigt | Guggenheim | Buy |
| 2025-06-13 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-06-09 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-04-23 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2025-03-19 | Eingeleitet | Stephens | Equal-Weight |
| 2025-03-11 | Bestätigt | BMO Capital Markets | Market Perform |
| 2025-03-03 | Hochstufung | Monness Crespi & Hardt | Sell → Neutral |
| 2025-01-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-12-20 | Herabstufung | Monness Crespi & Hardt | Neutral → Sell |
| 2024-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-09-16 | Hochstufung | Melius | Hold → Buy |
| 2024-09-10 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-09-10 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2024-06-17 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-04-18 | Eingeleitet | Oppenheimer | Perform |
| 2024-03-21 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-03-14 | Hochstufung | Argus | Hold → Buy |
| 2024-03-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2024-03-12 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-12-12 | Bestätigt | BMO Capital Markets | Market Perform |
| 2023-11-13 | Hochstufung | Edward Jones | Hold → Buy |
| 2023-10-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-15 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-14 | Hochstufung | DZ Bank | Hold → Buy |
| 2023-09-13 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2023-09-12 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2023-09-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-08-29 | Hochstufung | UBS | Neutral → Buy |
| 2023-06-13 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-04-20 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2023-03-10 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-01-18 | Eingeleitet | DA Davidson | Neutral |
| 2023-01-11 | Eingeleitet | Mizuho | Buy |
| 2023-01-09 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-01-05 | Hochstufung | Jefferies | Hold → Buy |
| 2022-10-21 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-20 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2022-09-14 | Eingeleitet | Berenberg | Hold |
| 2022-08-12 | Eingeleitet | Guggenheim | Buy |
| 2022-06-29 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2022-06-27 | Fortgesetzt | Goldman | Sell |
| 2022-06-14 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-04-01 | Eingeleitet | Daiwa Securities | Neutral |
| 2022-03-29 | Herabstufung | Exane BNP Paribas | Neutral → Underperform |
| 2022-03-11 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-03-11 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-12-21 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-12-15 | Hochstufung | DZ Bank | Sell → Hold |
| 2021-12-10 | Bestätigt | BMO Capital Markets | Market Perform |
| 2021-12-10 | Bestätigt | Barclays | Equal Weight |
| 2021-12-10 | Bestätigt | Citigroup | Neutral |
| 2021-12-10 | Bestätigt | Cowen | Outperform |
| 2021-12-10 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2021-12-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-12-10 | Bestätigt | Piper Sandler | Neutral |
| 2021-12-10 | Bestätigt | Societe Generale | Hold |
| 2021-12-10 | Bestätigt | Stifel | Hold |
| 2021-12-10 | Bestätigt | UBS | Neutral |
| 2021-12-10 | Bestätigt | Wolfe Research | Peer Perform |
| 2021-11-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-11-02 | Eingeleitet | Deutsche Bank | Hold |
| 2021-09-14 | Bestätigt | BMO Capital Markets | Market Perform |
| 2021-09-14 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-08-10 | Herabstufung | DZ Bank | Hold → Sell |
| 2021-05-10 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2021-04-23 | Eingeleitet | Wolfe Research | Peer Perform |
| 2021-04-21 | Herabstufung | DZ Bank | Buy → Hold |
| 2021-04-01 | Fortgesetzt | Wedbush | Neutral |
| 2021-03-22 | Fortgesetzt | Evercore ISI | In-line |
| 2021-03-16 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-03-11 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2021-03-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2021-03-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2021-03-03 | Fortgesetzt | Citigroup | Neutral |
| 2021-01-22 | Eingeleitet | Goldman | Sell |
| 2020-12-18 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-12-16 | Fortgesetzt | BofA Securities | Neutral |
| 2020-12-08 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-11-24 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | Fortgesetzt | UBS | Neutral |
| 2020-09-21 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-09-11 | Bestätigt | BMO Capital Markets | Market Perform |
| 2020-09-11 | Bestätigt | Barclays | Equal Weight |
| 2020-09-11 | Bestätigt | Credit Suisse | Outperform |
| 2020-09-11 | Bestätigt | Goldman | Buy |
| 2020-09-11 | Bestätigt | Jefferies | Hold |
| 2020-09-11 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2020-09-11 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-09-11 | Bestätigt | Stifel | Hold |
| 2020-09-11 | Bestätigt | Wells Fargo | Overweight |
| 2020-06-19 | Herabstufung | Argus | Buy → Hold |
| 2020-06-01 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2020-03-31 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2020-03-20 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-03-13 | Bestätigt | BMO Capital Markets | Market Perform |
Alle ansehen
Oracle Corp Aktie (ORCL) Neueste Nachrichten
Oracle Weighs Air Force Cloud Win Against AI Spending Lawsuits - Yahoo Finance
Lion Country Safari phases out some attractions after Oracle co-founder's purchase - WFLX
Oracle Seals Landmark CMS Cloud Deal, Solidifying Dominance in Federal Healthcare Infrastructure - FinancialContent
STOCK NEWS: Oracle Corporation Sued for Securities Fraud after 11% Stock Drop -- Investors Notified to Contact BFA Law by April 6 Class Action Deadline - The AI Journal
Key facts: Oracle's Stock Drops; Class Action Over AI Claims Filed; $25B AI Investment by 2026 - TradingView
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law Firm - GlobeNewswire Inc.
Oracle: A Look At The 6.6% Yielding Preferred Shares (NYSE:ORCL) - Seeking Alpha
Azerbaijani President meets with CEO of Oracle Corporation in Munich [VIDEO] - AzerNews
President Ilham Aliyev met with CEO of Oracle Corporation in Munich VIDEO - Azərtac
I Predicted That Oracle and Netflix Would Join Nvidia, Alphabet, Apple, Microsoft, Amazon, Broadcom, Meta Platforms, and Tesla in the $1 Trillion Club by 2030. Here's Why That Forecast Is Being Tested in 2026. - The Globe and Mail
Deadline Alert: Oracle Corporation (ORCL) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit - The AI Journal
Oracle Wins CMS Cloud Contract To Power Medicare, Medicaid Modernization - Yahoo Finance
As Oracle Lands a New Air Force Win, Should You Buy, Sell, or Hold ORCL Stock? - Barchart.com
Kessler Topaz Meltzer & Check, LLP has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation - FinancialContent
Bernstein trims target price on Oracle (ORCL) to $313 - MSN
The City of Atlanta Modernizes Constituent Services and Unlocks AI-Driven Innovation with Oracle - Investing News Network
Bernstein Trims Target Price on Oracle (ORCL) to $313 - Yahoo Finance
ReGrow Israel Harvests Insights from Oracle Data Intelligence for Agriculture to Support Agricultural Recovery and Future Resilience – Company AnnouncementFT.com - Financial Times
Longbow Finance SA Acquires 31,607 Shares of Oracle Corporation $ORCL - MarketBeat
Public Sector Pension Investment Board Purchases 237,097 Shares of Oracle Corporation $ORCL - MarketBeat
Oracle Corporation $ORCL Shares Sold by Financial Advocates Investment Management - MarketBeat
U.S. Department of the Air Force Accelerates Cloud Modernization with Oracle - marketscreener.com
81% of developers plan to migrate to OpenJDK as Oracle Java pricing concerns reach boiling point - IT Pro
Oracle Lands Key U.S. Government Cloud Deals as AI-Expansion Financing Questions Emerge - AD HOC NEWS
Oracle Corporation (ORCL) Investors: Kessler Topaz Meltzer & Check, LLP Announces That the Firm Has Filed a Securities Fraud Class Action Lawsuit Against Oracle Corporation and Encourages Investors to Contact the Firm - NewMediaWire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Oracle Corporation of Class Action Lawsuit and Upcoming DeadlinesORCL - PR Newswire
Oracle Corp awarded $88 million firm-fixed price task order by United States Department of Air Force - marketscreener.com
Investors in Oracle Corporation Should Contact Levi & Korsinsky Before April 6, 2026 to ... - Bluefield Daily Telegraph
Deadline Approaching: Oracle Corporation (ORCL) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. Smith - marketscreener.com
I Predicted Oracle Would Be the Hottest "Ten Titans" Stock to Buy in 2026, But the Growth Stock Is Already Down 27% This Year. Is Oracle Still a Buy? - Yahoo Finance
Oracle Corporation Class Action Notice for Investors - Intellectia AI
US military taps Oracle cloud services - Mobile World Live
Oracle suits up for Air Force Cloud One program with $88M contract - theregister.com
Oracle Stock Declines Amid OpenAI Partnership Concerns - Intellectia AI
Portnoy Law Firm Announces Class Action on Behalf of Oracle Corporation Investors - GlobeNewswire
How Oracle's AI Agents Will Power Automatous Procurement - Procurement Magazine
Is Oracle a Buy Now That It's Below $170? - The Globe and Mail
Bronstein, Gewirtz & Grossman LLC Urges Oracle Corporation - GlobeNewswire
Oracle Stock (ORCL) Rises on New U.S. Air Force Cloud Deal - TipRanks
Air Force awards Oracle $88 million cloud infrastructure contract - StreetInsider
Oracle Lawsuit Tests AI Growth Story And Investor Risk View - simplywall.st
Azul sees 10% increase in concern over Oracle Java pricing - Enterprise Times
Oracle’s $300 Billion Gamble: Inside the 4.5GW 'Stargate' Deal Redefining the AI Arms Race - FinancialContent
AI Boom: $1.63 Trillion Backlog for Microsoft, Oracle, AWS, Google Cloud - Cloud Wars
Oracle Secures Landmark CMS Cloud Contract, Cementing Its Dominance in Public Sector Healthcare Infrastructure - FinancialContent
Oracle's Strategic Surge: Defense Contract and AI Expansion Fuel Growth Ambitions - AD HOC NEWS
ORACLE CORPORATION (ORCL) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Oracle Corporation ... - Bluefield Daily Telegraph
ORACLE CORPORATION (ORCL) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Oracle Lands $88 Million Air Force Deal To Power Top Secret Military AI - Benzinga
Wedbush Securities Inc. Sells 4,425 Shares of Oracle Corporation $ORCL - MarketBeat
Finanzdaten der Oracle Corp-Aktie (ORCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):